TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of TVEC in Patients With Cutaneous Squamous Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE1
M6620 Plus Standard Treatment in Oesophageal and Other Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Using MC1R Genotype to Impact Melanoma Risk Behavior
- Status
- COMPLETED
- Phase
- NA
EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology
- Status
- COMPLETED
- Phase
- N/A
T-VEC in Non-melanoma Skin Cancer
- Status
- COMPLETED
- Phase
- PHASE1
QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)
- Status
- COMPLETED
- Phase
- PHASE2
Strategies to Promote Skin Health
- Status
- COMPLETED
- Phase
- NA